Amiodarone

Back to search

Molecule Structure

Scientific Name

Amiodarone

Description of the Drug

Amiodarone is a class III antiarrhythmic indicated for the treatment of recurrent hemodynamically unstable ventricular tachycardia and recurrent ventricular fibrillation.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01118

Brand Name(s)

Cordarone

Company Owner(s)

Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Akorn Operating Co Llc, Wyeth Pharmaceuticals Llc, Bedford Laboratories Div Ben Venue Laboratories Inc, Teva Pharmaceuticals Usa Inc, Rubicon Research Private Ltd, Fresenius Kabi Usa Llc, Hospira Inc, Acella Pharmaceuticals Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
HERG SINGLE PROTEIN BLOCKER CHEMBL240

Unichem Links

Atlas amiodarone
SureChEMBL SCHEMBL16284
PharmGKB PA448383
Human Metabolome Database HMDB0015250
DrugBank DB01118
PubChem: Thomson Pharma 14765719
PubChem 2157
Mcule MCULE-4156227717
LINCS LSM-2379
Nikkaji J7.829H
PDBe BBI
BindingDB 18957
EPA CompTox Dashboard DTXSID7022592
DrugCentral 176
Brenda 229155 229156 5758
ChemicalBook CB5310616
Guide to Pharmacology 2566
rxnorm PACERONE AMIODARONE HYDROCHLORIDE CORDARONE AMIODARONE NEXTERONE
KEGG Ligand C06823
ChEBI 2663
ZINC ZINC000003830212